Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma

[1]  P. Silverman.  Genetics and complexity. , 2004, The Hastings Center report.

[2]  C. Gerard,et al.  Complement in allergy and asthma. , 2002, Current opinion in immunology.

[3]  R. Jonsson,et al.  A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans , 2002, Nature Genetics.

[4]  D. Corry,et al.  Absence of the Complement Anaphylatoxin C3a Receptor Suppresses Th2 Effector Functions in a Murine Model of Pulmonary Allergy1 , 2002, The Journal of Immunology.

[5]  M. Munakata,et al.  A polymorphism in the human UGRP1 gene promoter that regulates transcription is associated with an increased risk of asthma. , 2002, American journal of human genetics.

[6]  Zhaohui S. Qin,et al.  Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. , 2002, American journal of human genetics.

[7]  N. Krug,et al.  Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. , 2001, American journal of respiratory and critical care medicine.

[8]  Rick A. Wetsel,et al.  Cutting Edge: The Absence of C3 Demonstrates a Role for Complement in Th2 Effector Functions in a Murine Model of Pulmonary Allergy1 , 2001, The Journal of Immunology.

[9]  G. T. De Sanctis,et al.  Genetics of allergen-induced asthma. , 2001, The Journal of allergy and clinical immunology.

[10]  J. Köhl,et al.  Anaphylatoxins and infectious and non-infectious inflammatory diseases. , 2001, Molecular immunology.

[11]  R. Barrington,et al.  The role of complement in inflammation and adaptive immunity , 2001, Immunological reviews.

[12]  J. Zabner,et al.  Expression of the Complement Anaphylatoxin C3a and C5a Receptors on Bronchial Epithelial and Smooth Muscle Cells in Models of Sepsis and Asthma1 , 2001, The Journal of Immunology.

[13]  D. Reich,et al.  Detecting association in a case‐control study while correcting for population stratification , 2001, Genetic epidemiology.

[14]  R. Ames,et al.  Cutting Edge: Guinea Pigs with a Natural C3a-Receptor Defect Exhibit Decreased Bronchoconstriction in Allergic Airway Disease: Evidence for an Involvement of the C3a Anaphylatoxin in the Pathogenesis of Asthma1 , 2000, The Journal of Immunology.

[15]  G. Peltz,et al.  Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma , 2000, Nature Immunology.

[16]  Bao Lu,et al.  A role for the C3a anaphylatoxin receptor in the effector phase of asthma , 2000, Nature.

[17]  Y. Matsubara,et al.  Mutation detection by TaqMan‐allele specific amplification: Application to molecular diagnosis of glycogen storage disease type Ia and medium‐chain acyl‐CoA dehydrogenase deficiency , 2000, Human mutation.

[18]  P. Henson.  Complementing asthma , 2000, Nature Immunology.

[19]  M. Wjst,et al.  A Genome-wide Search for Linkage to Asthma , 1999 .

[20]  N. Morton.  Genetic epidemiology , 1997, International Journal of Obesity.

[21]  E. Lander,et al.  Genome-Wide Search for Asthma Susceptibility Loci in a Founder Population , 1998 .

[22]  K C Barnes,et al.  The genetics and complexity of allergy and asthma. , 1998, Immunology today.

[23]  E. Lander,et al.  Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. , 1998, Human molecular genetics.

[24]  Farhad Imani,et al.  A genome-wide search for asthma susceptibility loci in ethnically diverse populations , 1997, Nature Genetics.

[25]  A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on the Genetics of Asthma (CSGA). , 1997, Nature genetics.

[26]  F. Finkelman,et al.  Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice , 1995, The Journal of experimental medicine.

[27]  L. Excoffier,et al.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.

[28]  C. Dahinden,et al.  The degradation product of the C5a anaphylatoxin C5adesarg retains basophil‐activating properties , 1994, European journal of immunology.

[29]  M. Church,et al.  Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. , 1994, The Journal of investigative dermatology.

[30]  T. Out,et al.  ELISA of complement C3a in bronchoalveolar lavage fluid. , 1992, Journal of immunological methods.

[31]  Lung,et al.  National asthma education program expert panel report. Guidelines for the diagnosis and management of asthma , 1991 .

[32]  Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. , 1991, The Journal of allergy and clinical immunology.

[33]  H. Müller-Eberhard,et al.  Molecular organization and function of the complement system. , 1988, Annual review of biochemistry.

[34]  C C Brown.  The validity of approximation methods for interval estimation of the odds ratio. , 1981, American journal of epidemiology.